Updates from Viatris
- Viatris Completes Acquisition of Pacira BioSciences (Company update · November 17, 2026)
The deal adds established treatments for acute postsurgical pain and osteoarthritis knee pain to the company's innovative medicines portfolio. - Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia (Product launch · October 16, 2026)
The U.S. Food and Drug Administration approved RYZUMVI, a phentolamine ophthalmic solution, for treating presbyopia in adults. - Viatris Announces Approval of WAKIX® (Pitolisant) in Japan (Product launch · September 16, 2026)
Japan's Ministry of Health, Labour and Welfare approved WAKIX for treating narcolepsy and excessive daytime sleepiness related to obstructive sleep apnea syndrome. It is the first histamine H3…